BGT

BIOGENETEC FPO [BGT]
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University for chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications, as well as insect management in crop protection. The company was incorporated in 1995 and is based in Melbourne, Australia.
Healthcare · ASX Small Cap
$0.0170 +0.0%

Updated 23 Jul 2026 · Signals refresh every scan

Get alerts when BGT triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track BGT — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Critical cash runway (1.7 quarters)
  • Strong revenue growth (+208%)
  • Near 52-week low (2% of range)
  • Micro-cap ($5-20M) - high risk
  • Capital raise activity (1 events)
  • CANSLIM S: Tight float (44%)
  • Sentiment is mixed — no strong consensus either way
  • Revenue growing at +208% — the top line is moving in the right direction
  • Altman Z-Score distress zone (0.74 < 1.81, low-confidence approx)
  • Penny stock risk ($0.017)
  • RBA hiking (-3pts)
  • Calendar: Quarterly 4C in 8d (+5pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 44% over the past year
  • The bigger volume days are the down days — volume-weighted momentum is negative (-3.16%/day)
Ask Scout AI about BGT
"What's driving BGT today?" "How does BGT compare to peers?" "Key risks for BGT?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Notice of Extraordinary General Meeting/Proxy Form
NONE Result of Security Purchase Plan
NONE Application for quotation of securities - BGT

Recent ASX Announcements

2026-07-06 Notice of Extraordinary General Meeting/Proxy Form
2026-06-23 Result of Security Purchase Plan
2026-06-23 Application for quotation of securities - BGT
2026-06-04 Update - Proposed issue of securities - BGT
2026-06-02 Investor Update Webinar

Key Metrics

$6.6M
Market Cap
607K
Avg Volume
0.3x
Vol Ratio
$0.02 — $0.06
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-202.2%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 44%
LLeader vs LaggardlaggardRS: -34
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

102 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
PIQ +23.3%SLD -18.1%ADR -17.9%IDT -17.1%VBS -14.3%
Compare:BGT vs PIQBGT vs SLDBGT vs ADR
Scout Pro — Deeper Analysis for BGT
Try Pro free for 30 days
Share this analysis

Track BGT and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required